(Reuters) -Hedge fund Starboard Value has taken a stake in Kenvue, the consumer products company that makes Band-Aid, ...
Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...
Adds Kenvue comment. Kenvue (NYSE:KVUE) needs to focus on fixing its skin, health and beauty segments, Jeff Smith, founder ...
Starboard Value called consumer products company Kenvue a bargain and said its skin health and beauty segment's lackluster ...
Kenvue has a formidable lineup of well-known consumer health brands, such as Aveeno, Tylenol, Band-Aid, Zirtec, Listerine, ...
BofA raised the firm’s price target on Kenvue (KVUE) to $27 from $24 and keeps a Buy rating on the shares. Noting that The Wall Street ...
Starboard Value contends that Kenvue, with strong consumer health brands like Tylenol and Listerine, is underperforming its ...
Kenvue (KVUE), a supplier of skin, healthcare, and beauty products, is a stock to consider buying. Starboard Value, an ...
The S&P 500 fell 0.2% on Monday. The Dow tumbled 0.8%, ending a three-day winning streak for the blue-chip index. After ...
Kenvue is a consumer products company that spun off from Johnson & Johnson in 2023. The split from Johnson & Johnson ( JNJ) ...